West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

and welcome to West's third quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask your question, please press star-1-1. To remove yourself from the queue, press star-1-1 again. We ask that you please limit yourselves to one question. As a reminder, this call may be recorded. I would like to turn the call over to John Sweeney, Vice President of Best Relations. Please go ahead. Good morning, and welcome to West's third quarter 2025 earnings conference call, which has been webcast live. With me today on the call are West CEO Eric Green and CFO Bob McMahon. Earlier today, we issued our third quarter financial results. A copy of the press release, along with today's slide presentation, containing supplement information for your reference, has been posted in the investor section of the company's website, located at investor.westfarmer.com. Later today, a replay of the webcast will also be available in the Investors section of our website. On the call, we will review our financial results and provide an update to our business and outlook for FY25. Statements made by management on the call and the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities law. These statements are based on our beliefs and assumptions, current expectations, estimates, and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results, as well as those expressed or implied in any forward-looking statements made here. Please refer to today's press release, as well as other disclosures made by the company regarding the risks ...